Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-130.22	-77.11	-33.49
Graham Fair Price	-13.98	22.25	25.86
PEG	-95.49	< 0.005	-0.14
Price/Book	-68.79	0.04	0.12
Price/Cash Flow	-14.31	-4.38	-3.83
Prices/Earnings	62.62	-0.13	-0.35
Price/Sales	-96.35	1.67	45.71
Price/FCF	-14.31	-4.38	-3.83
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	88.25	-19.46	-165.57
Operating Margin	88.88	-21.70	-195.08
ROA	16.22	< 0.005	< 0.005
ROE	-0.09	-0.07	16.52
ROIC	-0.02	-0.01	7.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.05	-28.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.04	0.08	113.48
EPS QOQ	-0.03	0.21	728.75
FCF QOQ	-0.19	0.74	285.32
Revenue QOQ	0.65	7.24	1006.59
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	173.70	18.63	-89.28
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.71	0.73	2.09
Quick Ratio	0.28	0.16	-43.05
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.58	17.49	-5.85
Cash	0.79	0.80	0.50
Capex	-0.01	< 0.005	30.53
Free Cash Flow	-0.59	-0.15	74.29
Revenue	0.05	0.40	704.87
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.47	0.23	-50.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-31.90	-76.01	-138.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating